Selas T F Bots

6PUBLICATIONS
6CO-AUTHORS
Molecular targetsArchaeology of New Guinea and Pacific Islands (excl. New Zealand)Predictive and prognostic markersNon-genetically modified uses of biotechnology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 01, 2023
Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma.

Selas T F Bots, Tom J Harryvan, Christianne Groeneveldt

|Feb 28, 2023
Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus 'GoraVir' in Cultured Pancreatic Cancer Cells.

Selas T F Bots, Sanne L Landman, Martijn J W E Rabelink

|Sep 09, 2022
Genome Analyses of Ten New Ape Adenoviruses with Similarity to Human Mastadenovirus C.

Selas T F Bots, Vera Kemp, Iris J C Dautzenberg

|Dec 04, 2021
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates.

Selas T F Bots, Vera Kemp, Steve J Cramer

|Sep 22, 2020
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy.

Lobke C M Hensen, Rob C Hoeben, Selas T F Bots

|Jul 12, 2020
Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?

Selas T F Bots, Rob C Hoeben

Pageof 1

Frequent Collaborators

5 joint publications

Rob C Hoeben

2 joint publications

Diana J M van den Wollenberg

1 joint publications

Lobke C M Hensen

1 joint publications

Vera Kemp